Cosmetic cross-reference Noindex: medium evidence

Sodium Octyl Sulfate

CAS 142-31-4

Sodium Octyl Sulfate (CAS 142-31-4) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
0
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Sodium Octyl Sulfate
CAS Number
142-31-4
UNII
6RZL727210
InChIKey
WFRKJMRGXGWHBM-UHFFFAOYSA-M
ChEMBL ID
CHEMBL556674
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Sodium Octyl Sulfate used for in pharmaceutical contexts?

Sodium Octyl Sulfate (CAS 142-31-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Sodium Octyl Sulfate?

No adverse-event association or SIDER side-effect rows are rendered for Sodium Octyl Sulfate in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Sodium Octyl Sulfate also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Sodium Caprylyl Sulfate with EU status "permitted".

What clinical phase is Sodium Octyl Sulfate in?

No phase 1-4 clinical development badge is rendered for Sodium Octyl Sulfate because the matched compound identifier rows do not contain a max-phase value.